Significant associated factors included older age, being male, health region, hospital level, insurance scheme, religion, occupation, GFR, HT comorbidity, HT duration, LVH, LAE, AF, DM duration, DN, DR and insulin, sulfonylurea, thiazolidinedione and aspirin therapy. This evidence concerns the gene INS and atrial fibrillation.